Dr. Guillermo Amescua began noting “something unusual” about the eye infections he was seeing in his clinic toward the end of last summer.
Amescua, a cornea specialist at the University of Miami Miller School of Medicine’s Bascom Palmer Eye Institute, was experienced in treating bacterial eye infections with drugs. The balmy Miami weather, he claimed, frequently tempts individuals to unwind at the beach or pool before taking out their contact lenses, providing bacteria—mostly Pseudomonas—with the ideal growing habitat.
Patients claim that their eyes hurt after becoming infected. They have blurry vision. They are light-sensitive. Amescua said that it is rarely a problem. We typically handle it, he said. “There is no issue.”
But the antibiotics in his arsenal are no longer effective. Amescua claimed that during the past six months, he has come across at least seven instances of Pseudomonas bacteria that are antibiotic-resistant and have catastrophic effects. According to the Centers for Disease Control and Prevention, the new strain belongs to a kind of Pseudomonas aeruginosa that has never been observed in the United States before.
The necessity for corneal transplants has existed. Some people experienced blindness.
“I was receiving difficulty after difficulty,” Amescua claimed. I can’t recall ever in my more than ten years losing the fight against a Pseudomonas infection so frequently in such little time.
The EzriCare Artificial Tears brand of eyedrops, according to the CDC, appears to be a common factor across instances across the country.
The agency urged people to stop using the eyedrops immediately.
[zombify_post]
0 Comments